Literature DB >> 30337473

Relation between opioid-related harms and socioeconomic inequalities in Ontario: a population-based descriptive study.

Zoe F Cairncross1, Jeremy Herring2, Trevor van Ingen2, Brendan T Smith2, Pamela Leece2, Brian Schwartz2, Karin Hohenadel2.   

Abstract

BACKGROUND: Negative health outcomes associated with the use of both prescribed and nonprescribed opioids are increasingly prevalent. We examined long-term trends in opioid-related harms in Ontario across a set of 6 indicators and the relation between harms and neighbourhood income in 2016.
METHODS: We examined rates of neonatal abstinence syndrome, opioid poisoning (fatal and nonfatal) and nonpoisoning opioid-related events from 2003 to 2016 in Ontario using population-based health administrative databases. We conducted descriptive analyses for harm indicators across neighbourhood income quintiles in 2016 (2015 for death). We examined social inequalities in opioid-related harms on both relative (prevalence ratio) and absolute (potential rate reduction) scales.
RESULTS: Rates of opioid-related harms increased dramatically between 2003 and 2016. In 2016, neonatal abstinence syndrome and opioid poisoning and nonpoisoning events showed a strong social gradient, with harm rates being lowest in higher-income neighbourhoods and highest in lower-income neighbourhoods. Prevalence ratios for the lowest-income neighbourhoods compared to the highest-income neighbourhoods ranged from 2.36 (95% confidence interval [CI] 2.15-2.58) for emergency department visits for opioid poisoning to 3.70 (95% CI 2.62-5.23) for neonatal abstinence syndrome. Potential rate reductions for opioid-related harms ranged from 34.8% (95% CI 29.1-40.1) to 49.9% (95% CI 36.7-60.5), which suggests that at least one-third of all harmful events could be prevented if all neighbourhoods had the same socioeconomic profile as the highest-income neighbourhoods.
INTERPRETATION: Rates of opioid-related harms increased in Ontario between 2003 and 2016, and people in lower-income neighbourhoods experienced substantially higher rates of opioid-related harms than those in higher-income neighbourhoods. This finding can inform planning for opioid-related public health interventions with consideration of health equity. Copyright 2018, Joule Inc. or its licensors.

Entities:  

Year:  2018        PMID: 30337473      PMCID: PMC6201733          DOI: 10.9778/cmajo.20180084

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  32 in total

1.  Look before you leap: stratify before you standardize.

Authors:  B C Choi; N A de Guia; P Walsh
Journal:  Am J Epidemiol       Date:  1999-06-15       Impact factor: 4.897

Review 2.  Opioids for chronic noncancer pain: a new Canadian practice guideline.

Authors:  Andrea D Furlan; Rhoda Reardon; Clarence Weppler
Journal:  CMAJ       Date:  2010-05-03       Impact factor: 8.262

3.  Increasing pregnancy-related use of prescribed opioid analgesics.

Authors:  Richard A Epstein; William V Bobo; Peter R Martin; James A Morrow; Wei Wang; Rameela Chandrasekhar; William O Cooper
Journal:  Ann Epidemiol       Date:  2013-08       Impact factor: 3.797

4.  Recent Developments in Prescription Opioid-related Dispensing and Harm Indicators in Ontario, Canada.

Authors:  Benedikt Fischer; Wayne Jones; Yoko Murphy; Anca Ialomiteanu; Jürgen Rehm
Journal:  Pain Physician       Date:  2015 Jul-Aug       Impact factor: 4.965

5.  Illicit drug overdose deaths resulting from income assistance payments: Analysis of the 'check effect' using daily mortality data.

Authors:  Michael C Otterstatter; Ashraf Amlani; Tianxiu Hugh Guan; Lindsey Richardson; Jane A Buxton
Journal:  Int J Drug Policy       Date:  2016-06-02

6.  Timing of income assistance payment and overdose patterns at a Canadian supervised injection facility.

Authors:  Maria Zlotorzynska; M-J S Milloy; Lindsey Richardson; Paul Nguyen; Julio S Montaner; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2014-04-04

7.  Acute neonatal effects of cocaine exposure during pregnancy.

Authors:  Charles R Bauer; John C Langer; Seetha Shankaran; Henrietta S Bada; Barry Lester; Linda L Wright; Heidi Krause-Steinrauf; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza; Joel Verter
Journal:  Arch Pediatr Adolesc Med       Date:  2005-09

8.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

9.  Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Kathi Hall; C Michael Stein
Journal:  JAMA       Date:  2016-06-14       Impact factor: 56.272

10.  Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

Authors:  Rachel Levinson-Castiel; Paul Merlob; Nehama Linder; Lea Sirota; Gil Klinger
Journal:  Arch Pediatr Adolesc Med       Date:  2006-02
View more
  8 in total

1.  Evaluation of opioid discontinuation after non-orthopaedic surgery among chronic opioid users: a population-based cohort study.

Authors:  Naheed K Jivraj; Damon C Scales; Tara Gomes; Jennifer Bethell; Andrea Hill; Ruxandra Pinto; Duminda N Wijeysundera; Hannah Wunsch
Journal:  Br J Anaesth       Date:  2020-01-27       Impact factor: 9.166

2.  Do statutory holidays impact the number of opioid-related hospitalizations among Canadian adults? Findings from a national case-crossover study.

Authors:  Chantal Houser; David Huynh; Amir Jasarevic; Minh T Do; Matthew Young; Paul J Villeneuve
Journal:  Can J Public Health       Date:  2020-08-07

3.  Stepping up to the Canadian opioid crisis: a longitudinal analysis of the correlation between socioeconomic status and population rates of opioid-related mortality, hospitalization and emergency department visits (2000-2017).

Authors:  Mhd Wasem Alsabbagh; Martin Cooke; Susan J Elliott; Feng Chang; Noor-Ul-Huda Shah; Marco Ghobrial
Journal:  Health Promot Chronic Dis Prev Can       Date:  2022-06       Impact factor: 2.725

4.  Opioid use and social disadvantage in patients with chronic musculoskeletal pain.

Authors:  Abby L Cheng; Brian K Brady; Ethan C Bradley; Ryan P Calfee; Lisa M Klesges; Graham A Colditz; Heidi Prather
Journal:  PM R       Date:  2021-05-03       Impact factor: 2.298

5.  Racial, Ethnic, and Socioeconomic Discrepancies in Opioid Prescriptions Among Older Patients With Cancer.

Authors:  Lucas K Vitzthum; Vinit Nalawade; Paul Riviere; Whitney Sumner; Tyler Nelson; Loren K Mell; Timothy Furnish; Brent Rose; María Elena Martínez; James D Murphy
Journal:  JCO Oncol Pract       Date:  2021-02-03

6.  Factors Associated With Opiate Use Among Psychiatric Inpatients: A Population-Based Study of Hospital Admissions in Ontario, Canada.

Authors:  Oluwakemi Aderibigbe; Anthony Renda; Christopher M Perlman
Journal:  Health Serv Insights       Date:  2019-11-22

Review 7.  Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review.

Authors:  Lucas Martignetti; Winnie Sun
Journal:  Cureus       Date:  2022-01-20

8.  Studying how state health services delivery policies can mitigate the effects of disasters on drug addiction treatment and overdose: Protocol for a mixed-methods study.

Authors:  Matthew D Eisenberg; Alexander McCourt; Elizabeth A Stuart; Lainie Rutkow; Kayla N Tormohlen; Michael I Fingerhood; Luis Quintero; Sarah A White; Emma Elizabeth McGinty
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.